<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>11046</id><no>HEM-PWRV1US</no><status>Open (affiliates only)</status><title>HEM-POWR: Observational Study Evaluating&#xD;
Effectiveness and Safety of Real-World Treatment with&#xD;
Damoctocog alfa pegol in Previously Treated Patients with&#xD;
Hemophilia A</title><secondary_protocol_no>HEM-POWR</secondary_protocol_no><nct_id>NCT03932201</nct_id><sponsor_type>Other</sponsor_type><age_group>Adult</age_group><treatment_type>Observational</treatment_type><phase>N/A</phase><disease_site>Other</disease_site><PI>Kessler, Craig</PI><institution>Georgetown University Medical Center; Lombardi Comprehensive Cancer Center</institution><management_group>GUMC Medicine Hem-Onc</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>